Search for: "TRIS PHARMA, INC."
Results 61 - 80
of 124
Sorted by Relevance
|
Sort by Date
4 Apr 2009, 10:28 am
The painkiller has since been pulled from the market by Pfizer Inc. [read post]
10 Jun 2009, 10:00 pm
Purdue Pharma Co., 2006 WL 263602, at *3 n.6 (M.D. [read post]
24 May 2019, 10:46 pm
The $100,000 payment Medical Informatics Engineering, Inc. [read post]
3 Jul 2008, 7:26 pm
Tri Hawk International, 985 F.2d 208 (5th Cir. [read post]
12 Oct 2021, 5:12 pm
Appendix to the HTSUS (“USITC Pharma. [read post]
25 Jul 2008, 2:11 am
See Aventis Pharma Deutschland GmbH v. [read post]
5 Mar 2014, 2:46 pm
Medtronic, Inc., U.S. [read post]
23 Aug 2007, 8:06 am
Purdue Pharma, L.P., 295 F.Supp.2d 693, 705 (E.D. [read post]
22 Dec 2009, 8:57 pm
Purdue Pharma, 438 F.3d at 1136. [read post]
9 Nov 2009, 6:01 am
Big Pharma's off-label transgressions didn't trigger a rush for the doors by shareholders. [read post]
5 Jul 2008, 11:05 am
: (Spicy IP), Aspen pays £170M for IP rights to Eltroxin, Imuran, Lanoxin and Zyloric: (Afro-IP), Year after settling global patent feud over smallpox vaccine, Barvarian Nordic sues Oxford BioMedica over patents related to same virus: (IP Law360), Australia: Age reports former GSK executive’s victory in court action brought by GSK alleging he started a competing business using GSK’s confidential information: (IPwar’s), Brazil: ANVISA to review Brazilian… [read post]
25 Jan 2008, 1:00 am
: (IP ThinkTank),IBM patents and defensive publishing: (Securing Innovation),Stockholm Network paper on developing nations and pharmaceutical patents: (IPcentral Weblog),Good and bad news for the IP industry if recession does bite: (IAM),Business Software Alliance: Piracy economic impact is tens of billions of dollars: (Ars Technica),IP portfolio costs - when less is more: (IP ThinkTank),IP protection: Competitive market default: (The Fire… [read post]
26 Feb 2011, 3:47 pm
Mayne Pharma (USA) Inc., 467 F.3d 1370, 1379 (Fed. [read post]
17 Apr 2008, 10:39 am
Schwarz Pharma, Inc., ___ F. [read post]
23 Aug 2008, 1:23 am
: (Part 1 - SPICY IP), (Part 2 - SPICY IP) Global – Copyright International Federation of the Phonographic Industry (IFPI): ‘Three strikes’ effort hit worldwide home run: (Ars Technica), How to attribute a Creative Commons licensed work: (Molly Kleinman), Chrysalis disappoints, as new artists fail to incubate: (IP finance), DRM for streaming music dies a quiet death: (Electronic Frontier Foundation), (Techdirt) Events 26 August:… [read post]
19 Jul 2022, 2:59 pm
BioMimetic Therapeutics, Inc., 2013 WL 139521, at *13-14 (M.D. [read post]
19 Sep 2008, 6:00 pm
: (Spicy IP), India: Supreme Court on exclusive marketing rights: (Spicy IP), Japan: First induced pluripotent stem (iPS) cell patent at Kyoto University: (Competitive Info), Slovenia: Supplementary protection certificates in Slovenia: (The SPC Blog), United States: Biotech/pharma lobbying scoreboard – second quarter update – part II: (Patent Docs), United States: Ferring Pharmaceuticals argues to bring down direct purchaser suits: (Law 360), United States: Transferred… [read post]
31 Dec 2015, 5:12 am
We bid SBA adieu here.Amarin Pharma, Inc. v. [read post]
9 Aug 2011, 4:30 am
Boehringer Ingelheim Pharma., Inc., C.A. [read post]
12 Nov 2010, 7:52 am
Pharma, arms suppliers and tobacco industries have also been targeted in the past year. [read post]
